Stay updated on Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in HAE Clinical Trial page.

Latest updates to the Lanadelumab in HAE Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2; the study record content is unchanged.SummaryDifference0.1%

- Check26 days agoChange DetectedA banner announces that NIH agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs. It appears above the study record and does not change the trial details.SummaryDifference0.7%

- Check33 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study record history now shows a new revision entry (v3.7.0) replacing the previous v3.6.6. This reflects an update to the record version rather than changes to study data.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history and the previous revision v3.6.5 was removed, indicating an update to the page's revision metadata.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in HAE Clinical Trial page.